Loss of Primary Cilia Potentiates <i>BRAF/MAPK</i> Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (<i>CROCC</i>) Alterations

A rhabdoid colorectal tumor (RCT) is a rare cancer with aggressive clinical behavior. Recently, it has been recognized as a distinct disease entity, characterized by genetic alterations in the <i>SMARCB1</i> and Ciliary Rootlet Coiled-Coil (<i>CROCC</i>). We here investigate...

Full description

Bibliographic Details
Main Authors: Andrea Remo, Federica Grillo, Luca Mastracci, Michele Simbolo, Matteo Fassan, Maria Paola Cecchini, Giuseppe Miscio, Antonio Sassano, Paola Parente, Alessandro Vanoli, Giovanna Sabella, Guido Giordano, Emanuele Damiano Urso, Luigi Cerulo, Aldo Scarpa, Francesco Fiorica, Massimo Pancione
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/14/5/984
_version_ 1797600061177200640
author Andrea Remo
Federica Grillo
Luca Mastracci
Michele Simbolo
Matteo Fassan
Maria Paola Cecchini
Giuseppe Miscio
Antonio Sassano
Paola Parente
Alessandro Vanoli
Giovanna Sabella
Guido Giordano
Emanuele Damiano Urso
Luigi Cerulo
Aldo Scarpa
Francesco Fiorica
Massimo Pancione
author_facet Andrea Remo
Federica Grillo
Luca Mastracci
Michele Simbolo
Matteo Fassan
Maria Paola Cecchini
Giuseppe Miscio
Antonio Sassano
Paola Parente
Alessandro Vanoli
Giovanna Sabella
Guido Giordano
Emanuele Damiano Urso
Luigi Cerulo
Aldo Scarpa
Francesco Fiorica
Massimo Pancione
author_sort Andrea Remo
collection DOAJ
description A rhabdoid colorectal tumor (RCT) is a rare cancer with aggressive clinical behavior. Recently, it has been recognized as a distinct disease entity, characterized by genetic alterations in the <i>SMARCB1</i> and Ciliary Rootlet Coiled-Coil (<i>CROCC</i>). We here investigate the genetic and immunophenotypic profiling of 21 RCTs using immunohistochemistry and next-generation sequencing. Mismatch repair-deficient phenotypes were identified in 60% of RCTs. Similarly, a large proportion of cancers exhibited the combined marker phenotype (CK7-/CK20-/CDX2-) not common to classical adenocarcinoma variants. More than 70% of cases displayed aberrant activation of the mitogen-activated protein kinase (MAPK) pathway with mutations prevalently in <i>BRAF</i> V600E. SMARCB1/INI1 expression was normal in a large majority of lesions. In contrast, ciliogenic markers including CROCC and γ-tubulin were globally altered in tumors. Notably, CROCC and γ-tubulin were observed to colocalize in large cilia found on cancer tissues but not in normal controls. Taken together, our findings indicate that primary ciliogenesis and MAPK pathway activation contribute to the aggressiveness of RCTs and, therefore, may constitute a novel therapeutic target.
first_indexed 2024-03-11T03:43:11Z
format Article
id doaj.art-f4456b4ea4294361885c722c5609db5c
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-11T03:43:11Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-f4456b4ea4294361885c722c5609db5c2023-11-18T01:28:52ZengMDPI AGGenes2073-44252023-04-0114598410.3390/genes14050984Loss of Primary Cilia Potentiates <i>BRAF/MAPK</i> Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (<i>CROCC</i>) AlterationsAndrea Remo0Federica Grillo1Luca Mastracci2Michele Simbolo3Matteo Fassan4Maria Paola Cecchini5Giuseppe Miscio6Antonio Sassano7Paola Parente8Alessandro Vanoli9Giovanna Sabella10Guido Giordano11Emanuele Damiano Urso12Luigi Cerulo13Aldo Scarpa14Francesco Fiorica15Massimo Pancione16Pathology Unit, Services Department, ULSS9 “Scaligera”, 37122 Verona, ItalyAnatomic Pathology, Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa and Ospedale Policlinico San Martino, 16132 Genoa, ItalyAnatomic Pathology, Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa and Ospedale Policlinico San Martino, 16132 Genoa, ItalyDepartment of Diagnostic and Public Health, Section of Pathology, University of Verona, 37135 Verona, ItalyDepartment of Medicine (DIMED), Surgical Pathology Unit, University of Padua, 35128 Padua, ItalyDepartment of Neurosciences, Biomedicine and Movement Sciences, Anatomy and Histology Section, University of Verona, 37135 Verona, ItalyUnit of Pathology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, ItalyUnit of Pathology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, ItalyUnit of Pathology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, ItalyAnatomic Pathology Unit, Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy1st Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, ItalyU.O.C. Oncologia Medica, Ospedali Riuniti Azienda Ospedaliera Universitaria, 71100 Foggia, ItalyDepartment of Surgical, Oncological and Gastroenterological Sciences, University of Padua, 35128 Padua, ItalyDepartment of Sciences and Technologies, University of Sannio, 82100 Benevento, ItalyDepartment of Diagnostic and Public Health, Section of Pathology, University of Verona, 37135 Verona, ItalyRadiotherapy Unit, Oncology Department, ULSS9 “Scaligera”, 37122 Verona, ItalyDepartment of Sciences and Technologies, University of Sannio, 82100 Benevento, ItalyA rhabdoid colorectal tumor (RCT) is a rare cancer with aggressive clinical behavior. Recently, it has been recognized as a distinct disease entity, characterized by genetic alterations in the <i>SMARCB1</i> and Ciliary Rootlet Coiled-Coil (<i>CROCC</i>). We here investigate the genetic and immunophenotypic profiling of 21 RCTs using immunohistochemistry and next-generation sequencing. Mismatch repair-deficient phenotypes were identified in 60% of RCTs. Similarly, a large proportion of cancers exhibited the combined marker phenotype (CK7-/CK20-/CDX2-) not common to classical adenocarcinoma variants. More than 70% of cases displayed aberrant activation of the mitogen-activated protein kinase (MAPK) pathway with mutations prevalently in <i>BRAF</i> V600E. SMARCB1/INI1 expression was normal in a large majority of lesions. In contrast, ciliogenic markers including CROCC and γ-tubulin were globally altered in tumors. Notably, CROCC and γ-tubulin were observed to colocalize in large cilia found on cancer tissues but not in normal controls. Taken together, our findings indicate that primary ciliogenesis and MAPK pathway activation contribute to the aggressiveness of RCTs and, therefore, may constitute a novel therapeutic target.https://www.mdpi.com/2073-4425/14/5/984rhabdoid colorectal tumorsrare cancersCiliary Rootlet Coiled-Coil (CROCC)<i>SMARCB1</i>
spellingShingle Andrea Remo
Federica Grillo
Luca Mastracci
Michele Simbolo
Matteo Fassan
Maria Paola Cecchini
Giuseppe Miscio
Antonio Sassano
Paola Parente
Alessandro Vanoli
Giovanna Sabella
Guido Giordano
Emanuele Damiano Urso
Luigi Cerulo
Aldo Scarpa
Francesco Fiorica
Massimo Pancione
Loss of Primary Cilia Potentiates <i>BRAF/MAPK</i> Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (<i>CROCC</i>) Alterations
Genes
rhabdoid colorectal tumors
rare cancers
Ciliary Rootlet Coiled-Coil (CROCC)
<i>SMARCB1</i>
title Loss of Primary Cilia Potentiates <i>BRAF/MAPK</i> Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (<i>CROCC</i>) Alterations
title_full Loss of Primary Cilia Potentiates <i>BRAF/MAPK</i> Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (<i>CROCC</i>) Alterations
title_fullStr Loss of Primary Cilia Potentiates <i>BRAF/MAPK</i> Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (<i>CROCC</i>) Alterations
title_full_unstemmed Loss of Primary Cilia Potentiates <i>BRAF/MAPK</i> Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (<i>CROCC</i>) Alterations
title_short Loss of Primary Cilia Potentiates <i>BRAF/MAPK</i> Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (<i>CROCC</i>) Alterations
title_sort loss of primary cilia potentiates i braf mapk i pathway activation in rhabdoid colorectal carcinoma a series of 21 cases showing ciliary rootlet coiledcoil i crocc i alterations
topic rhabdoid colorectal tumors
rare cancers
Ciliary Rootlet Coiled-Coil (CROCC)
<i>SMARCB1</i>
url https://www.mdpi.com/2073-4425/14/5/984
work_keys_str_mv AT andrearemo lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT federicagrillo lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT lucamastracci lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT michelesimbolo lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT matteofassan lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT mariapaolacecchini lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT giuseppemiscio lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT antoniosassano lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT paolaparente lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT alessandrovanoli lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT giovannasabella lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT guidogiordano lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT emanueledamianourso lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT luigicerulo lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT aldoscarpa lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT francescofiorica lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations
AT massimopancione lossofprimaryciliapotentiatesibrafmapkipathwayactivationinrhabdoidcolorectalcarcinomaaseriesof21casesshowingciliaryrootletcoiledcoilicroccialterations